Healthcare
B Capital closes US-Asia healthcare fund on $500m
US and Asia-focused VC firm B Capital has closed its first dedicated sector fund, collecting USD 500m for investments in healthcare.
China vaccine developer Immorna raises $100m
Immorna, a China-based biotech start-up focused on RNA-based therapeutics and vaccines, has raised about USD 100m across two Series A extensions.
China's Oricell secures $45m Series B extension
Qatar Investment Authority (QIA) and RTW Investments, a US-based healthcare investor, have led a Series B extension of USD 45m for Oricell Therapeutics, a China-based drug developer working on CAR-T cell therapies.
Q&A: Blackbird Ventures’ Rick Baker
Rick Baker, co-founder of Australia’s Blackbird Ventures, on pricing adjustments in the tech space, fundraising and secondaries, valuing unicorns, and the rise of ChatGPT
Cenova leads $40m Series B for China's Eluminex
China-based healthcare investor Cenova Capital has led a USD 40m Series B round for Eluminex Biosciences, which is developing drugs and regenerative tissue used to treat eye disease and other vision-threatening medical conditions.
Kotak fund invests $129m in India's Biocon
Kotak Mahindra Advisors (KIA), the alternative assets arm of Kotak Mahindra Group, has committed INR 10.7bn (USD 129.4m) to Indian pharmaceuticals manufacturer Biocon to support the latter’s acquisition of a biosimilar business from global healthcare...
Anchorage agrees carve-out from New Zealand's Green Cross Health
Anchorage Capital Partners has agreed to buy New Zealand-based Green Cross Health’s community healthcare business – which provides in-home nursing, personal care, rehabilitation, social support, and household assistance services – for an enterprise...
PeerCapital hits $37m first close on India early-stage fund
PeerCapital, an Indian venture capital firm that participates in seed and Series A rounds, has reached a first close of INR 3bn (USD 36.3m) on its debut fund.
Eight Roads builds out China team
Eight Roads Ventures has added three partners to its China team through promotion, bringing the total number in the country to 10.
China medical device manufacturer gets Series D backing
China-based medical device manufacturer Hygea Medical Technology has raised more than CNY 100m (USD 15m) in Series D funding led by healthcare-focused In Capital.
AVCJ Awards 2022: Fundraising of the Year – Venture Capital: Qiming Venture Partners
Qiming Venture Partners defied tough conditions to close its eighth US dollar-denominated fund on USD 2.5bn. Managing Partner Nisa Leung looks back on the process and examines the prospects for healthcare
Advantage exits Japan dental supplier to local strategic
Japan’s Advantage Partners has agreed to sell Dental Holding, a local dental industry equipment distribution company, to Askul, an office equipment supplier, after a 2.5-year hold.
Goldman raises $5.2b global growth fund
Goldman Sachs Asset Management (GSAM) has closed its debut global growth fund with USD 5.2bn in commitments. It claims this is one of the largest first-time growth vehicles ever raised globally.
LP interview: Quilvest Capital Partners
Fund-of-funds Quilvest Capital Partners was an early-mover in PE globally but has maintained a lean profile that speaks to its family office roots. It is pressing ahead with a China and India-focused Asia strategy
Fund focus: ChrysCapital accumulates $1.4b India war chest
For ChrysCapital Partners, raising India’s largest private equity fund reflects the growth in the economy and in the investment opportunity, with bigger deals across more sectors on the agenda
China's Structure Therapeutics soars on US debut
Structure Therapeutics, a China and US-based drug developer specialising in novel oral therapeutics, performed strongly on its trading debut following an upsized USD 161.1m NASDAQ IPO.
Japan's Global Brain, Meiji Yasuda launch $39m VC fund
Japan’s Global Brain has further extended a string of corporate VC partnerships, teaming up with Meiji Yasuda Life Insurance to launch a JPY 5bn (USD 39m) fund.
MBK buys Japan aged care business
MBK Partners has acquired Unimat Retirement Community (URC), a Japan-based company that primarily provides in-home and residential nursing care services.
India exits: Sustainable trend?
GPs saw abundant exits in India in 2021 and the flow continued last year even as other markets stumbled. Investors must assess the merits of various contributing cyclical and structural factors
India's Enzene Biosciences raises $50m
Indian biotech company Enzene Biosciences has raised a USD 50m round featuring Eight Roads Ventures and F-Prime Capital.
MBK, Unison Korea pursue dental implant buyout
MBK Partners and Unison Capital Korea have launched a tender offer for Osstem Implant, a Korea-based manufacturer of dental implants, that values the company at approximately KRW 2.85trn (USD 2.3bn).
China cell therapy developer raises $75m
Iaso Biotherapeutics, a Chinese cell therapy developer focusing on oncology treatments, has raised nearly CNY 500m (USD 75m) in an extended Series C round.
ADB backs Quadria's third health fund
Asian Development Bank (ADB) has committed USD 25m to the third fund from Singapore-based Quadria Capital, a healthcare-focused private equity firm.
GP profile: LeapFrog Investments
LeapFrog Investments is broadly recognised as a pioneer of impact investing globally as well as an architect of the industry’s legitimising standards and controls. Asia has always been core